Most Recent

image: All Eyes On Stem Cells

All Eyes On Stem Cells

By | October 1, 2014

See the striking images behind the quest to develop stem cell therapeutics for vision disorders.

0 Comments

image: H.M.’s Brain

H.M.’s Brain

By | May 9, 2014

See the striking images behind the quest to develop stem cell therapeutics for vision disorders.

0 Comments

image: Renard's Menagerie

Renard's Menagerie

By | January 1, 2014

See the striking images behind the quest to develop stem cell therapeutics for vision disorders.

0 Comments

image: Out of Sight

Out of Sight

By | September 1, 2013

See the striking images behind the quest to develop stem cell therapeutics for vision disorders.

0 Comments

image: STW: In the Field

STW: In the Field

By | August 1, 2013

See the striking images behind the quest to develop stem cell therapeutics for vision disorders.

0 Comments

image: Making Good on Research

Making Good on Research

By | June 1, 2013

See the striking images behind the quest to develop stem cell therapeutics for vision disorders.

0 Comments

image: Game On

Game On

By | January 3, 2013

See the striking images behind the quest to develop stem cell therapeutics for vision disorders.

0 Comments

image: The Birthday Conference

The Birthday Conference

By | November 1, 2012

See the striking images behind the quest to develop stem cell therapeutics for vision disorders.

0 Comments

image: Mummy's Little Secret

Mummy's Little Secret

By | November 1, 2012

See the striking images behind the quest to develop stem cell therapeutics for vision disorders.

0 Comments

image: Self-Medicating Animals

Self-Medicating Animals

By | October 23, 2012

See the striking images behind the quest to develop stem cell therapeutics for vision disorders.

1 Comment

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech